These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Matrix metalloproteinases in squamous cell carcinoma. Johansson N; Kähäri VM Histol Histopathol; 2000 Jan; 15(1):225-37. PubMed ID: 10668212 [TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Matsunaga Y; Koda M; Murawaki Y Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313 [TBL] [Abstract][Full Text] [Related]
9. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Pittayapruek P; Meephansan J; Prapapan O; Komine M; Ohtsuki M Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271600 [TBL] [Abstract][Full Text] [Related]
10. Biology of metalloproteinases. Amălinei C; Căruntu ID; Bălan RA Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181 [TBL] [Abstract][Full Text] [Related]
11. Role of matrix metalloproteinases in melanoma cell invasion. Hofmann UB; Houben R; Bröcker EB; Becker JC Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317 [TBL] [Abstract][Full Text] [Related]
12. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Kähäri VM; Saarialho-Kere U Ann Med; 1999 Feb; 31(1):34-45. PubMed ID: 10219712 [TBL] [Abstract][Full Text] [Related]
14. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases. Kim IS; Yang WS; Kim CH Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851 [TBL] [Abstract][Full Text] [Related]
15. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. Vosseler S; Lederle W; Airola K; Obermueller E; Fusenig NE; Mueller MM Int J Cancer; 2009 Nov; 125(10):2296-306. PubMed ID: 19610062 [TBL] [Abstract][Full Text] [Related]
16. Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma. Tampa M; Georgescu SR; Mitran MI; Mitran CI; Matei C; Caruntu A; Scheau C; Nicolae I; Matei A; Caruntu C; Constantin C; Neagu M Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204372 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases in human melanoma. Hofmann UB; Westphal JR; Van Muijen GN; Ruiter DJ J Invest Dermatol; 2000 Sep; 115(3):337-44. PubMed ID: 10951266 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases (MMPs) in health and disease: an overview. Malemud CJ Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]